Mehrotra S, Dhasmana A, Gupta T K, Parmar S S, Barthwal J P
Res Commun Chem Pathol Pharmacol. 1987 Jun;56(3):421-4.
Newly synthesized indolylimidazolones were tested for their in vitro monoamine oxidase (MAO) inhibitory activity. These compounds were found to possess analgesic activity and anticonvulsant activity against maximal electroshock-induced convulsions in mice. The low toxicity of these compounds was reflected by their high approximate LD50 values.
对新合成的吲哚基咪唑啉酮进行了体外单胺氧化酶(MAO)抑制活性测试。发现这些化合物具有镇痛活性,并且对小鼠最大电休克诱导的惊厥具有抗惊厥活性。这些化合物的低毒性体现在其较高的近似半数致死量(LD50)值上。